Hypertension was the most frequent comorbidities (63.2%), and two patients had ever used angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II type-I receptor blockers (ARBs) (patient 1 and patient 7). This evidence concerns the gene ACE and Hypertension.